Inhibrx Biosciences, Inc. INBX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Inhibrx Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s cash ratio?
- Inhibrx Biosciences, Inc. (INBX) reported cash ratio of 6.1× in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s cash ratio changed year-over-year?
- Inhibrx Biosciences, Inc.'s cash ratio increased by 22.9% year-over-year, from 5× to 6.1×.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s cash ratio?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s cash ratio has grown at a -13.7% compound annual growth rate (CAGR), from 4.9× to 3.7×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.